e-learning
resources
Amsterdam 2011
Sunday, 25.09.2011
Multidrug-resistant tuberculosis
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
First second line anti-tuberculosis drug resistance survey in Romania
D. Homorodean, I. Husar, C. Popa, F. Cojocaru, E. Ibraim (Cluj-Napoca, Bucharest, Romania; Dieppe, France)
Source:
Annual Congress 2011 - Multidrug-resistant tuberculosis
Session:
Multidrug-resistant tuberculosis
Session type:
Oral Presentation
Number:
397
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
D. Homorodean, I. Husar, C. Popa, F. Cojocaru, E. Ibraim (Cluj-Napoca, Bucharest, Romania; Dieppe, France). First second line anti-tuberculosis drug resistance survey in Romania. Eur Respir J 2011; 38: Suppl. 55, 397
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Expert interview: TB-Machine learning and artificial intelligence as allies in clinical decision
Debate -Tuberculosis: Rolling out of new drugs without diagnostic capacities
Panel discussion on unprecedented progress in shortening treatment for TB: Evidence to date, and future possibilities
Related content which might interest you:
Treatment of migrants with tuberculosis in an era of emerging drug resistance
Source: Annual Congress 2010 - Tuberculosis drug resistance and migration
Year: 2010
Impact of African immigration on drug resistance to
mycobacterium tuberculosis
in Portugal
Source: Annual Congress 2011 - Tuberculosis in special populations
Year: 2011
Second-line tuberculosis drug resistance study from a referal center of Turkey
Source: Annual Congress 2008 - Clinical epidemiology of tuberculosis II
Year: 2008
First-line anti-TB drug resistance pattern and its trend in the national TB referral center in Iran
Source: Annual Congress 2008 - Clinical epidemiology of tuberculosis III
Year: 2008
Increasing TB drug resistance in Moldova during the 2006-2010
Source: Annual Congress 2011 - Multidrug-resistant tuberculosis
Year: 2011
Tuberculosis screening among intravenous drug users (IDU) in Georgia
Source: Annual Congress 2011 - Tuberculosis in special populations
Year: 2011
Trend of acquired drug resistance to main anti TB drugs in the first 7 years of applying DOT strategy in Iasi County, Romania
Source: Annual Congress 2007 - Tuberculosis control
Year: 2007
Spreading of resistance to group A anti-tuberculosis drugs among TB patients in Astana city
Source: International Congress 2018 – Drug-resistant tuberculosis and the sequelae of pulmonary tuberculosis
Year: 2018
Investigating trends in antituberculosis (anti-TB) drug resistance among treated patients of a university respiratory infections unit in Greece
Source: Annual Congress 2009 - Treatment of tuberculosis at times of emerging drug resistance
Year: 2009
First line anti-tuberculous drug resistance prevalence and its pattern among HIV infected patients in the national referral TB center, Iran
Source: Annual Congress 2009 - Tuberculosis and HIV co-infection
Year: 2009
Frequency of drug resistance and treatment results in patients with newly detected tuberculosis using standard chemotherapeutical regimen on the data of district hospital, Kiev
Source: Eur Respir J 2002; 20: Suppl. 38, 402s
Year: 2002
Frequency of drug resistance and treatment results with standard chemotherapeutical regimen in patients with newly detected tuberculosis on the data of district hospital, Kiev
Source: Eur Respir J 2002; 20: Suppl. 38, 548s
Year: 2002
The comparative analysis of treatment effectiveness in children and adolescents with MDR TB with anti-TB drugs of the first and second lines
Source: Annual Congress 2012 - Tuberculous and non-tuberculous mycobacterial infections: epidemiology II
Year: 2012
Anti-tuberculosis drug resistance in Sivas, Turkey
Source: Annual Congress 2007 - Epidemiological and clinical aspects of tuberculosis control
Year: 2007
Is multidrug-resistant tuberculosis on the rise in Mozambique? Results of a national drug resistance survey
Source: Eur Respir J 2011; 37: 222-224
Year: 2011
Trends in antituberculous drug resistance pattern between 1990 and 2000 in a tuberculous reference hospital in Turkey
Source: Eur Respir J 2002; 20: Suppl. 38, 403s
Year: 2002
Increasing anti-tuberculosis drug resistance in the UK
Source: Annual Congress 2008 - Multidrug-resistant and the emerging threat of extensively drug-resistant tuberculosis
Year: 2008
Bacteriological conversion in XDR-TB and RR-TB patients with fluoroquinolone resistance treated with and without new and repurposed anti-TB drugs in Azerbaijan prisons
Source: International Congress 2018 – Drug-resistant tuberculosis
Year: 2018
A study of prescription of second line drugs in chronic tuberculosis patients before confirmation of multi drug resistance bacteriologically
Source: Annual Congress 2010 - Special treatment options in tuberculosis
Year: 2010
Frequency of resistance to antituberculosis drugs in 2003 year
Source: Eur Respir J 2004; 24: Suppl. 48, 654s
Year: 2004
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept